Health & Environmental Research Online (HERO)


Print Feedback Export to File
1003606 
Journal Article 
Proteomic analysis of arsenite - Mediated multiple antibiotic resistance in Yersinia enterocolitica biovar 1A 
Mallik, S; Virdi, JS; Johri, AK 
In Press 
Yes 
Journal of Basic Microbiology
ISSN: 0233-111X
EISSN: 1521-4028 
52 
306-313 
English 
Arsenic is one of the most important global environmental pollutants. In the present study, fifty one clinical strains of Yersinia enterocolitica biovar 1A showed high resistance to arsenite and arsenate. The minimum inhibitory concentration (MIC) of arsenite (0.625-20 mM) was lower than arsenate (10-80 mM). Growth of Y. enterocolitica in 2 mM arsenite led to 2-8 fold increase in MICs of the five antibiotics (amikacin, ciprofloxacin, gentamycin, kanamycin and tetracycline), suggesting expression of arsenite-induced multiple antibiotic resistance among the strains. Proteomic analysis of Y. enterocolitica revealed differential expression of certain proteins following arsenite exposure, which included a putative outer membrane porin (OmpA) and a putative amino acid transporter protein. In conclusion, modulation of membrane permeability may be involved in the induction of arsenite-mediated expression of multiple antibiotic resistance in Y. enterocolitica. (© 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim). 
Yersinia enterocolitica; Arsenic resistance; Multiple antibiotic resistance; MALDI-TOF; MS 
IRIS
• Arsenic Hazard ID
     1. Initial Lit Search
          PubMed
          WOS
          ToxNet
          WOS
          Considered New
     2. Lit Search Updates through Oct 2015
          WOS
          Considered
     4. Considered through Oct 2015
     6. Cluster Filter through Oct 2015
     7. Other Studies through Oct 2015
          Other
• Arsenic (Inorganic)
     1. Literature
          PubMed
          Toxline, TSCATS, & DART
          Web of Science
          Lit search updates through Oct 2015
     3. Hazard ID Screening
          Other potentially supporting studies
     4. Adverse Outcome Pathways/Networks Screening
          Excluded/Not relevant
               Title/Abstract screening